Showing results (51-60 of 62) with videos related to
Sort By:
Pageof 7
Nucleic Acids Research|June 27, 2024
ONECUT2 acts as a lineage plasticity driver in adenocarcinoma as well as neuroendocrine variants of prostate cancerChen Qian, Qian Yang, Mirja Rotinen, et al.Journal of the National Comprehensive Cancer Network : JNCCN|June 2, 2026
Pathogenic Germline Variants in a Racially Diverse Real-World Cohort of Patients With Prostate CancerTaylor B Crawford, Maliha Tayeb, Emanuel Barrett, et al.Theranostics|June 28, 2019
A Circulating Tumor Cell-RNA Assay for Assessment of Androgen Receptor Signaling Inhibitor Sensitivity in Metastatic Castration-Resistant Prostate CancerYu Jen Jan, Junhee Yoon, Jie-Fu Chen, et al.Medrxiv : the Preprint Server for Health Sciences|February 20, 2025
Specificity of a polygenic score for aggressive prostate cancerAnna M Dornisch, George J Xu, Roshan Karunamuni, et al.Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 8, 2022
The Movember Global Action Plan 1 (GAP1): Unique Prostate Cancer Tissue Microarray ResourceVéronique Ouellet, Andrew Erickson, , et al.European Urology|May 29, 2020
Transcriptomic Heterogeneity of Gleason Grade Group 5 Prostate CancerAmar U Kishan, Tahmineh Romero, Mohammed Alshalalfa, et al.JAMA Network Open|December 29, 2021
Comparison of Response to Definitive Radiotherapy for Localized Prostate Cancer in Black and White Men: A Meta-analysisTing Martin Ma, Tahmineh Romero, Nicholas G Nickols, et al.BMC Public Health|September 17, 2024
Adaptation of the socioecological model to address disparities in engagement of Black men in prostate cancer genetic testingAmy E Leader, Timothy R Rebbeck, William K Oh, et al.Journal of the National Comprehensive Cancer Network : JNCCN|March 10, 2023
NCCN Guidelines® Insights: Prostate Cancer Early Detection, Version 1.2023Kelvin A Moses, Preston C Sprenkle, Clinton Bahler, et al.Nature Genetics|July 22, 2020
Prostate cancer reactivates developmental epigenomic programs during metastatic progressionMark M Pomerantz, Xintao Qiu, Yanyun Zhu, et al.Pageof 7